Rulide: Advanced Macrolide Antibiotic for Effective Bacterial Infection Control
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.04 | $62.25 (0%) | 🛒 Add to cart |
| 90 | $0.95 | $93.38 $85.34 (9%) | 🛒 Add to cart |
| 120 | $0.88 | $124.50 $105.42 (15%) | 🛒 Add to cart |
| 180 | $0.80 | $186.75 $143.58 (23%) | 🛒 Add to cart |
| 270 | $0.71 | $280.13 $191.77 (32%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $373.50 $244.98 (34%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.31 | $46.19 (0%) | 🛒 Add to cart |
| 30 | $2.21 | $69.28 $66.27 (4%) | 🛒 Add to cart |
| 60 | $2.01 | $138.56 $120.48 (13%) | 🛒 Add to cart |
| 90 | $1.81 | $207.84 $162.65 (22%) | 🛒 Add to cart |
| 120 | $1.61 | $277.11 $192.77 (30%) | 🛒 Add to cart |
| 180 | $1.41 | $415.67 $253.02 (39%) | 🛒 Add to cart |
| 270 | $1.20 | $623.51 $325.31 (48%) | 🛒 Add to cart |
| 360 | $1.10
Best per pill | $831.34 $397.60 (52%) | 🛒 Add to cart |
Synonyms | |||
Rulide (roxithromycin) is a semi-synthetic macrolide antibiotic designed for the targeted treatment of a wide spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis, effectively halting the growth and proliferation of susceptible organisms. This medication is particularly valued in clinical practice for its favorable pharmacokinetic profile, including high tissue penetration and a sustained half-life that supports convenient twice-daily dosing. Its broad-spectrum activity makes it a reliable choice for respiratory, skin, and soft tissue infections, offering clinicians a potent therapeutic tool within the macrolide class.
Features
- Active pharmaceutical ingredient: Roxithromycin 150 mg or 300 mg per tablet.
- Pharmacological class: Macrolide antibiotic.
- Mechanism of action: Binds to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis.
- Spectrum of activity: Effective against Gram-positive bacteria (e.g., Streptococcus pneumoniae, Streptococcus pyogenes), some Gram-negative bacteria (e.g., Moraxella catarrhalis), and atypical pathogens (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila).
- Bioavailability: Approximately 50%, significantly increased when administered postprandially.
- Half-life: Approximately 12 hours, enabling a convenient twice-daily dosage regimen.
- Excretion: Primarily via the bile into the feces, with a small portion excreted in urine.
- Presentation: Film-coated tablets for oral administration.
Benefits
- Effective Bacterial Eradication: Provides potent bactericidal and bacteriostatic action against a clinically relevant range of pathogens, leading to successful resolution of infections.
- Convenient Dosing Schedule: The extended half-life allows for twice-daily administration, which can improve patient adherence to the treatment regimen compared to antibiotics requiring more frequent dosing.
- High Tissue Penetration: Achieves excellent concentration at the site of infection, particularly in lung tissue, tonsils, sinuses, and skin, ensuring the drug reaches the pathogenic bacteria effectively.
- Generally Well-Tolerated Profile: Exhibits a favorable tolerability spectrum, with a lower incidence of severe gastrointestinal side effects compared to some older macrolides like erythromycin.
- Utility in Penicillin-Allergic Patients: Serves as a valuable alternative therapeutic option for patients with a confirmed hypersensitivity to penicillin antibiotics, where clinically appropriate.
Common use
Rulide is indicated for the treatment of mild to moderate bacterial infections caused by susceptible strains of microorganisms. Its primary use cases include:
- Upper Respiratory Tract Infections: Such as pharyngitis, tonsillitis, sinusitis, and otitis media.
- Lower Respiratory Tract Infections: Including acute bacterial bronchitis, community-acquired pneumonia, and exacerbations of chronic bronchitis.
- Skin and Soft Tissue Infections: Such as erysipelas, impetigo, and secondary infected dermatoses.
- Genitourinary Infections: Notably non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis.
The decision to prescribe Rulide should be based on the suspected or proven pathogen and local susceptibility patterns to ensure appropriate use and help combat antibiotic resistance.
Dosage and direction
The dosage of Rulide must be individualized based on the type and severity of the infection, as well as patient-specific factors. The following represents standard adult and pediatric dosing. Always follow the precise dosage prescribed by a physician.
- Adults and children over 40 kg: The usual dose is 300 mg per day. This can be administered as 300 mg once daily or 150 mg twice daily. For more severe infections, the dose may be increased to 300 mg twice daily (600 mg total daily dose).
- Children under 40 kg: The recommended dose is 2.5 - 5 mg per kg of body weight, twice daily. Specific pediatric formulations or careful tablet splitting may be required, as directed by a pediatrician.
- Administration: Tablets should be swallowed whole with a full glass of water and are ideally taken with food to enhance absorption and minimize potential gastrointestinal discomfort.
- Duration of Therapy: A typical course of treatment lasts from 5 to 10 days, depending on the clinical response. It is crucial to complete the entire prescribed course of therapy, even if symptoms improve, to prevent relapse and the development of antibiotic resistance.
Precautions
- Hepatic Impairment: Rulide should be administered with caution in patients with pre-existing liver dysfunction or hepatic impairment, as the drug is extensively metabolized in the liver. Liver function tests should be considered during prolonged therapy.
- Prolonged Use: Extended antibiotic treatment can result in the overgrowth of non-susceptible organisms, including fungi or Clostridioides difficile, which may lead to secondary infections like antibiotic-associated colitis.
- QT Prolongation: Like other macrolides, roxithromycin has the potential to prolong the cardiac QT interval. Use with extreme caution in patients with known QT prolongation, significant bradycardia, or electrolyte imbalances (e.g., hypokalemia, hypomagnesemia), and in those taking other drugs known to prolong the QT interval.
- Myasthenia Gravis: Macrolides have been associated with exacerbating symptoms of myasthenia gravis, including muscle weakness and respiratory distress. They should be used with great caution in this patient population.
- Renal Impairment: While dosage adjustment is not usually necessary in mild to moderate renal impairment, caution is advised in patients with severe renal insufficiency (creatinine clearance <30 mL/min).
Contraindications
Rulide is contraindicated in patients with:
- A known hypersensitivity to roxithromycin, any other macrolide antibiotic (e.g., erythromycin, azithromycin, clarithromycin), or any of the excipients in the formulation.
- Concomitant administration with ergotamine, dihydroergotamine, or other ergot derivatives due to the risk of severe ergotism (peripheral vasospasm and ischemia).
- Concomitant administration with drugs that are potent CYP3A4 substrates and known to prolong the QT interval, such as astemizole, terfenadine, cisapride, or pimozide, due to a high risk of serious cardiac arrhythmias.
Possible side effect
As with all pharmaceuticals, Rulide can cause side effects, although not everybody gets them. Most are mild to moderate and transient.
- Common (≥1/100 to <1/10): Gastrointestinal disturbances are most frequent and include abdominal pain, nausea, vomiting, diarrhea, dyspepsia, and loss of appetite. Headache and dizziness have also been reported.
- Uncommon (≥1/1,000 to <1/100): Skin reactions such as rash, pruritus (itching), and urticaria (hives). Alterations in taste perception, and transient increases in liver enzymes.
- Rare (≥1/10,000 to <1/1,000): Severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis), hepatitis, cholestatic jaundice, anaphylactic reactions, and Clostridioides difficile-associated diarrhea.
- Frequency not known: Cardiac arrhythmias (including QT prolongation and torsades de pointes), hearing loss (usually reversible upon discontinuation), and exacerbation of myasthenia gravis.
Patients should be advised to contact their healthcare provider if any side effect becomes severe or persistent.
Drug interaction
Rulide is a moderate inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme system and may interact with drugs metabolized by this pathway, leading to increased plasma concentrations of the co-administered drug.
- Contraindicated Combinations: Ergot derivatives (ergotamine, dihydroergotamine), terfenadine, astemizole, cisapride, pimozide.
- Significant Interactions Requiring Caution/Monitoring/Dose Adjustment:
- Statins: Increased risk of myopathy/rhabdomyolysis with simvastatin and lovastatin. Consider using a non-interacting statin.
- Anticoagulants: (e.g., warfarin) may have enhanced effects. Increased monitoring of INR is required.
- Cyclosporine, Tacrolimus: Increased plasma levels of these immunosuppressants, increasing the risk of nephro- and neurotoxicity. Close monitoring of levels is essential.
- Midazolam, Triazolam: Increased sedative effect.
- Theophylline: Potential for increased theophylline serum levels; monitor for signs of toxicity.
- Digoxin: May increase digoxin serum concentration by altering gut flora.
- Other QT-prolonging agents: (e.g., certain antipsychotics, antiarrhythmics, fluoroquinolones) co-administration increases the risk of life-threatening cardiac arrhythmias.
A comprehensive review of a patient’s medication list, including over-the-counter drugs and herbal supplements, is mandatory before initiating therapy with Rulide.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped.
- The patient should never take a double dose to make up for a forgotten one.
- Maintaining a consistent schedule is important for maintaining effective antibiotic levels in the body.
Overdose
- Symptoms of overdose are likely to be an extension of the drug’s known adverse effects, primarily severe nausea, vomiting, diarrhea, and abdominal cramps.
- There is no specific antidote for roxithromycin overdose.
- Management should consist of symptomatic and supportive care, including ensuring adequate hydration and electrolyte balance.
- Gastric lavage may be considered if performed shortly after ingestion.
- Medical attention should be sought immediately in case of suspected overdose.
Storage
- Store below 30°C (86°F).
- Keep the tablets in their original blister pack or container to protect them from light and moisture.
- Keep out of the sight and reach of children.
- Do not use the medicine after the expiry date printed on the packaging.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As a pulmonologist, I find Rulide to be a highly effective and reliable choice for treating community-acquired pneumonia, especially in areas with high rates of atypical pathogens. The b.i.d. dosing is a significant advantage for outpatient compliance.” – Dr. E. Lawson, MD
- “In my dermatology practice, Rulide has provided excellent results for patients with moderate skin and soft tissue infections. Its tolerability profile is superior to older macrolides, leading to better patient completion of therapy.” – Dr. A. Chen, Dermatologist
- “We frequently use Rulide as a second-line agent for upper respiratory infections in penicillin-allergic patients. It has consistently demonstrated good clinical efficacy and a predictable safety profile.” – Clinical Pharmacist, General Hospital